Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Oklahomans should not have to fight their health insurer for the right to breathe. Blue Cross Blue Shield must abandon this new policy.

Although people should have the right to eat soda, candy, and other less nutritious foods, the federal government shouldn't ...

WASHINGTON (AP) — Government advisers were split Thursday on whether drugmakers need to update their COVID-19 vaccines for next season, a decision overshadowed by confusion over a new Trump ...

The Supreme Court sided with the vaping industry on Friday by rejecting the Food and Drug Administration’s (FDA) bid to limit where companies can challenge product marketing denials. The ...

Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml).

Regeneron on Wednesday said the FDA green light covers Lynozyfic in adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a ...

Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment Provided by Dow Jones Jul 2, 2025, 3:39:00 PM. By Colin Kellaher .